Cytokinetics (CYTK) Operating Expenses (2016 - 2025)
Historic Operating Expenses for Cytokinetics (CYTK) over the last 16 years, with Q4 2024 value amounting to $156.0 million.
- Cytokinetics' Operating Expenses rose 2082.04% to $156.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $554.7 million, marking a year-over-year increase of 1012.18%. This contributed to the annual value of $554.7 million for FY2024, which is 1012.18% up from last year.
- As of Q4 2024, Cytokinetics' Operating Expenses stood at $156.0 million, which was up 2082.04% from $141.3 million recorded in Q3 2024.
- Cytokinetics' 5-year Operating Expenses high stood at $156.0 million for Q4 2024, and its period low was $34.2 million during Q1 2020.
- Its 5-year average for Operating Expenses is $94.2 million, with a median of $105.4 million in 2022.
- As far as peak fluctuations go, Cytokinetics' Operating Expenses surged by 10446.53% in 2021, and later crashed by 156.17% in 2024.
- Quarter analysis of 5 years shows Cytokinetics' Operating Expenses stood at $43.1 million in 2020, then soared by 79.24% to $77.3 million in 2021, then surged by 66.86% to $129.0 million in 2022, then grew by 0.08% to $129.1 million in 2023, then grew by 20.82% to $156.0 million in 2024.
- Its Operating Expenses was $156.0 million in Q4 2024, compared to $141.3 million in Q3 2024 and $130.4 million in Q2 2024.